Transcatheter Mitral & Tricuspid Therapies (TMTTs) are the future of Edwards - Estimated to be a more than $5 billion opportunity by 2028, Edwards will...

Professional Education & Development Manager DACH (d/f/m) - Surgical Vision - 2406199206W Description At Johnson & Johnson, we believe health is everything....